TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic

Brain Stimul. 2021 Nov-Dec;14(6):1508-1510. doi: 10.1016/j.brs.2021.09.007. Epub 2021 Sep 23.
No abstract available

Keywords: CBTI; Cognitive behavioral therapy for insomnia; Depression; Insomnia; TMS; Transcranial magnetic stimulation.

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Cognitive Behavioral Therapy*
  • Depression
  • Depressive Disorder, Major* / epidemiology
  • Depressive Disorder, Major* / therapy
  • Feasibility Studies
  • Humans
  • Pandemics
  • SARS-CoV-2
  • Sleep Initiation and Maintenance Disorders* / epidemiology
  • Sleep Initiation and Maintenance Disorders* / therapy
  • Transcranial Magnetic Stimulation
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT04258618